IMMUNE AND CYTOKINE STATUS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING ALEMTUZUMAB

In present work, we studied cytokine levels and performed analysis of some immunologic parameters in the patients with chronic lymphocytic leukemia (CLL) before and after treatment with monoclonal anti-CD52 antibody (alemtuzumab). In comparison with a control group, the CLL patients before alemtuzum...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: M. N Khorobrykh, T. P. Zagoskina, V. I. Shardakov, E. L. Nazarova, A. V. Yovdiy
Format: article
Langue:RU
Publié: SPb RAACI 2014
Sujets:
Accès en ligne:https://doaj.org/article/d104345a4c674536b7bed7af0f268234
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!